glp 1 for bmi under 27 Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial Medicare GLP-1 Bridge Eligibility: BMI

Fecal BA is a cost-effective, accurate biomarker, and it is associated with obvious bowel dysfunction in IBS-D and IBS-C patients

If you have a different lifestyle, and you only want to do keto or you want to do veggie, thats already there for you

GLP-1 drugs are effective because they delay the stomach from emptying, creating a feeling of fullness, thereby having an increased effect on weight loss

Many patients experience reduced appetite and fluid intake when starting GLP-1 therapy, whilst the medicine's gastrointestinal effects including nausea and occasional vomiting can further affect hydration status